131 related articles for article (PubMed ID: 1893349)
1. Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy.
Ajani JA; Ota DM; Jessup JM; Ames FC; McBride C; Boddie A; Levin B; Jackson DE; Roh M; Hohn D
Cancer; 1991 Oct; 68(7):1501-6. PubMed ID: 1893349
[TBL] [Abstract][Full Text] [Related]
2. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
Ajani JA; Roth JA; Ryan B; McMurtrey M; Rich TA; Jackson DE; Abbruzzese JL; Levin B; DeCaro L; Mountain C
J Clin Oncol; 1990 Jul; 8(7):1231-8. PubMed ID: 2358838
[TBL] [Abstract][Full Text] [Related]
4. Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report.
Crookes P; Leichman CG; Leichman L; Tan M; Laine L; Stain S; Baranda J; Casagrande Y; Groshen S; Silberman H
Cancer; 1997 May; 79(9):1767-75. PubMed ID: 9128994
[TBL] [Abstract][Full Text] [Related]
5. Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma.
Ajani JA; Mansfield PF; Lynch PM; Pisters PW; Feig B; Dumas P; Evans DB; Raijman I; Hargraves K; Curley S; Ota DM
J Clin Oncol; 1999 Aug; 17(8):2403-11. PubMed ID: 10561303
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.
Kelsen D; Karpeh M; Schwartz G; Gerdes H; Lightdale C; Botet J; Lauers G; Klimstra D; Huang Y; Saltz L; Quan V; Brennan M
J Clin Oncol; 1996 Jun; 14(6):1818-28. PubMed ID: 8656250
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction.
Ajani JA; Roth JA; Putnam JB; Walsh G; Lynch PM; Roubein LD; Ryan MB; Natrajan G; Gould P
Eur J Cancer; 1995; 31A(5):665-70. PubMed ID: 7640036
[TBL] [Abstract][Full Text] [Related]
8. Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
Ajani JA; Roth JA; Ryan MB; Putnam JB; Pazdur R; Levin B; Gutterman JU; McMurtrey M
J Clin Oncol; 1993 Jan; 11(1):22-8. PubMed ID: 8418237
[TBL] [Abstract][Full Text] [Related]
9. Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program.
Leichman L; Silberman H; Leichman CG; Spears CP; Ray M; Muggia FM; Kiyabu M; Radin R; Laine L; Stain S
J Clin Oncol; 1992 Dec; 10(12):1933-42. PubMed ID: 1453207
[TBL] [Abstract][Full Text] [Related]
10. A preliminary study of preoperative chemotherapy combining irinotecan and cisplatin in patients with gastric cancer with unresectable para-aortic lymph node metastases.
Yamao T; Ohta K; Ohyama S; Ishihara S; Chin K; Maruyama M; Takahashi T; Nakajima T
Jpn J Clin Oncol; 2004 May; 34(5):255-61. PubMed ID: 15231860
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study.
Ott K; Sendler A; Becker K; Dittler HJ; Helmberger H; Busch R; Kollmannsberger C; Siewert JR; Fink U
Gastric Cancer; 2003; 6(3):159-67. PubMed ID: 14520529
[TBL] [Abstract][Full Text] [Related]
12. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
[TBL] [Abstract][Full Text] [Related]
13. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer.
Noh SH; Yoo CH; Chung HC; Roh JK; Shin DW; Min JS
Oncology; 2001; 60(1):24-30. PubMed ID: 11150904
[TBL] [Abstract][Full Text] [Related]
14. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
Bamias A; Hill ME; Cunningham D; Norman AR; Ahmed FY; Webb A; Watson M; Hill AS; Nicolson MC; O'Brien ME; Evans TC; Nicolson V
Cancer; 1996 May; 77(10):1978-85. PubMed ID: 8640659
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.
Atiq OT; Kelsen DP; Shiu MH; Saltz L; Tong W; Niedzwiecki D; Trochanowski B; Lin S; Toomasi F; Brennan M
J Clin Oncol; 1993 Mar; 11(3):425-33. PubMed ID: 8445416
[TBL] [Abstract][Full Text] [Related]
16. Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.
Melcher AA; Mort D; Maughan TS
Br J Cancer; 1996 Nov; 74(10):1651-4. PubMed ID: 8932350
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601.
Findlay M; Storey D; Gebski V; Hargreaves C; Cullingford G; Boyer M; Trotter J; Archer S; Davidson A; Johnston P; Yuen J; Dhillon H; Della-Fiorentina S; Richardson G; Truskett P; Goldstein D;
ANZ J Surg; 2007 Apr; 77(4):247-52. PubMed ID: 17388828
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.
Bamias A; Cunningham D; Nicolson V; Norman A; Hill M; Nicolson M; O'Brien M; Webb A; Hill A
Br J Cancer; 1995 Mar; 71(3):583-6. PubMed ID: 7880742
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
[TBL] [Abstract][Full Text] [Related]
20. [Advanced gastric cancer curatively resected following combined neoadjuvant chemotherapy--report of a case].
Koike N; Ohwada S; Ogawa T; Kawashima K; Takeyoshi I; Sato Y; Kamiyama H; Morishita Y
Gan To Kagaku Ryoho; 1998 May; 25(6):919-23. PubMed ID: 9617332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
